News

Young Adults Blast 'Stupid Cancer' With Social Networking


 

FROM THE ANNUAL CONFERENCE OF THE AMERICAN PSYCHOSOCIAL ONCOLOGY SOCIETY

"Most important, they provide a sense that you are not alone, and there are other people just like you," said Mr. Mlot.

Involvement can be strictly online, through chat rooms, or on Facebook, or can involve direct meetings with other survivors at local chapter events or national conferences, striking back at the isolation many young cancer patients describe.

Fulfillment also comes in the form of volunteering for the organization, said Mr. Mlot, cochair of the group in the Florida region, and a graduating senior geography major at University of Florida in Gainesville.

"I know how it feels when you first start the cancer journey, so I feel like I can be helpful to people first facing it."

Cancer Facts: Adolescents and Young Adults

• 70,000 adolescents and young adults diagnosed with cancer each year.

• About 1.4 million young adult cancer survivors in the United States.

• 1 in 100 college students is a cancer survivor.

• Cancer is the leading disease-related cause of death in adolescents/young adults.

• White, non-Hispanic adolescents/young adults have the highest incidence and the highest 5-year survival rates.

• American Indian and Alaskan Native adolescents/young adults have the lowest cancer incidence but also have poor 5-year survival rates.

• African Americans have the lowest 5-year survival rates.

• Incidence of some forms of cancer in adolescents/young adults is rising; for example, melanoma.

• In contrast to young children and older adults, survival rates in adolescents and young adults have not improved in decades

Sources:

National Cancer Institute: "A Snapshot of Adolescent and Young Adult Cancer" (Updated September 2010)

NCI: "Closing the Gap" 2006

i[2]y I’m Too Young For This! Cancer Foundation

No relevant financial disclosures were reported by the individuals quoted in this story.

Pages

Recommended Reading

Anti-MEK-PI3K Drug Combination Reduces Lesions in Solid Tumors
MDedge Hematology and Oncology
FDA Keeping an Eye on New Malignancy Concerns With Lenalidomide
MDedge Hematology and Oncology
ASCO, NCCN Recommend EGFR Testing in Advanced Lung Cancer
MDedge Hematology and Oncology
BRCA2 Gene Mutation Linked With Improved Survival in Ovarian Cancer
MDedge Hematology and Oncology
Stomach, Esophageal Cancer Risks Increased in AIDS Patients
MDedge Hematology and Oncology
Panel Backs Everolimus for Pancreatic Neuroendocrine Tumors
MDedge Hematology and Oncology
FDA Panel Backs Sunitinib for Pancreatic Neuroendocrine Tumors
MDedge Hematology and Oncology
Laparoscopic Hepatic Resection Found Safe For HCC Patients With Cirrhosis
MDedge Hematology and Oncology
FDA Approves Peginterferon Alfa-2b for Melanoma
MDedge Hematology and Oncology
Cancer Survivorship Programs Key To Serving Patients
MDedge Hematology and Oncology